Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020		Mar. 31, 2019
Cash used for operating activities
Net income	$ 282		$ 176
Depreciation and Amortization	283		258	[1]
Provision for (Benefit from) Deferred Income Tax	26		(220)
Net Periodic Pension Benefit	(102)		(75)
Pension Contributions	(28)		(50)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments	46		(65)
Restructuring and Asset Related Charges - Net	70		61
Amortization of inventory step-up	0		205
Other net loss	138		92
Changes in operating assets and liabilities - net	(2,645)		(2,436)
Cash used for operating activities	(1,930)		(1,541)
Cash used for investing activities
Capital expenditures	(128)		(663)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested	11		125
Proceeds from sales of ownership interests in nonconsolidated affiliates	0		21
Purchases of investments	(67)		(16)
Proceeds from Sale and Maturities of Investments	58		36
Other investing activities - net	(4)		(5)
Cash used for investing activities	(130)		(502)
Cash provided by financing activities
Net change in borrowings (less than 90 days)	1,619		814
Proceeds from debt	875		1,000
Payments on Debt	(1)		(284)
Payments for Repurchase of Common Stock	(50)		0
Proceeds from Stock Options Exercised	14		35
Payments of Dividends	(97)		0
Distributions to DowDuPont	0		(317)
Contributions from Dow	0		88
Other financing activities	(16)		(24)
Cash provided by financing activities	2,344		1,312
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(117)		20
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash	167		(711)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Company, Beginning of Period	2,173		5,024
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Company, End of Period	2,340	[2]	4,313
EID [Member]
Cash used for operating activities
Net income	258		176
Depreciation and Amortization	283		258
Provision for (Benefit from) Deferred Income Tax	26		(220)
Net Periodic Pension Benefit	(102)		(75)
Pension Contributions	(28)		(50)
Net loss (gain) on sales of property, businesses, consolidated companies, and investments	46		(65)
Restructuring and Asset Related Charges - Net	70		61
Amortization of inventory step-up	0		205
Other net loss	138		92
Changes in operating assets and liabilities - net	(2,613)		(2,436)
Cash used for operating activities	(1,922)		(1,541)
Cash used for investing activities
Capital expenditures	(128)		(663)
Proceeds from the sale of property, businesses, and consolidated companies, net of cash divested	11		125
Proceeds from sales of ownership interests in nonconsolidated affiliates	0		21
Purchases of investments	(67)		(16)
Proceeds from Sale and Maturities of Investments	58		36
Other investing activities - net	(4)		(5)
Cash used for investing activities	(130)		(502)
Cash provided by financing activities
Net change in borrowings (less than 90 days)	1,619		814
Repayments of Related Party Debt	(148)		0
Proceeds from debt	875		1,000
Payments on Debt	(1)		(284)
Proceeds from Stock Options Exercised	14		35
Distributions to DowDuPont	0		(317)
Contributions from Dow	0		88
Other financing activities	(23)		(24)
Cash provided by financing activities	2,336		1,312
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(117)		20
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash	167		(711)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Company, Beginning of Period	2,173		5,024
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Company, End of Period	2,340		4,313
Total company [Member]
Cash used for operating activities
Depreciation and Amortization	283		726
Restructuring and Asset Related Charges - Net	70		106
Total company [Member] | EID [Member]
Cash used for operating activities
Depreciation and Amortization	283		726
Restructuring and Asset Related Charges - Net	$ 70		$ 106

[1] Period is presented on a pro forma basis, prepared in accordance with Article 11 of Regulation S-X.

[2] See page 19 for reconciliation of cash and cash equivalents and restricted cash presented in interim Condensed Consolidated Balance Sheets to total cash, cash equivalents and restricted cash presented in the interim Condensed Consolidated Statements of Cash Flows.